Archive for the ‘Commentary’ Category

Right Turn: FFB is funding and keeping an eye on vision research

Author: Stacey Johnson, 05/19/17

Dr. Mary Sunderland is quite at ease talking to a video camera. The Director of Research & Education for the Foundation Fighting Blindness (FFB) has been hosting Facebook Live sessions on a variety of topics related to vision research for the past six months. If she was nervous when she began these public outreach sessions…Read more

Filling the void: A scientist’s introduction to commercialization/clinical translation

Author: Holly Wobma, 04/26/17

For anybody who has invested a great deal of time into a research project, you probably feel a certain sense of expertise on the topic. Sure, it is impossible to know a whole field (every answer raises more questions), and lab work is rife with puzzlement and failures, but at the end of the day,…Read more

Major League Baseball Pitchers and “Stem Cell” therapy

Author: David Kent, 04/18/17

With the Toronto Blue Jays* off to a terrible start, I was almost dissuaded from reading anything about baseball, until I happened upon the following article: “Stem-cell therapy is poised to disrupt the Tommy John epidemic in baseball.” First, I had to do my standard “fake news” check by triangulating the sources, readings, etc., but…Read more

Right Turn: Sightings of innovation in Canada

Author: Stacey Johnson, 04/14/17

If you are a knowledge worker, it may seem as though “innovation” is on everyone’s lips these days. First, Canadians saw Industry Canada renamed Innovation, Science and Economic Development when Prime Minister Trudeau unveiled his first cabinet. Then, Budget 2017, titled “building a strong middle class” could have had “the innovation budget” as its working…Read more

The long slog of medical R&D and finding inspiration

Author: Elizabeth Csaszar, 03/27/17

Research and development (R&D) of a medical therapeutic is a long slog. This isn’t news to anyone working in the field. The average time to bring a new drug product to market is over a decade. Moreover, this is the timeline when everything progresses well – funding and business decisions align, manufacturing processes come together,…Read more

Right Turn: Synthetic biology predicted to become a huge industry

Author: Stacey Johnson, 02/10/17

There is a trend in the regenerative medicine field to include gene therapies when describing the work being performed by academics and industry, as in “cell and gene therapies.” The wider definition better reflects how the industry is evolving and acknowledges the dual focus. I expect the same may happen with synthetic biology’s role in…Read more

Peter Zandstra and CCRM: Making cell therapies a commercial reality

Author: Guest, 01/31/17

Dr. Rohin Iyer is currently a Development Manager at GE Healthcare / CCRM. He did his PhD in Biomedical Engineering at the University of Toronto, and has been working in the field of stem cells and tissue engineering for over 12 years. He is an avid tweeter (follow @DrRohinIyer) on cell therapies and regenerative medicine. …Read more

Right Turn: W.O.M.E.N. in Advanced Therapies welcoming members

Author: Stacey Johnson, 01/20/17

A special thing happened this week at Phacilitate’s Cell and Gene Therapy World: W.O.M.E.N. in Advanced Therapies launched. The virtual group is the result of conversations begun more than a year ago with like-minded individuals who want to give women the tools they need to succeed in an industry – like many – where there…Read more

Making a case for research investment in Canada: Can we drive reverse brain drain now?

Author: Camila Londono, 01/11/17

Brain drain was a real problem for Canada in the late ‘90s. A study by Statistics Canada found that twice as many post-secondary professors and teachers went to the United States than came to Canada in that period. This untenable situation—in which education and infrastructure investments in people were lost through decreased funding, higher taxes…Read more

Inaugural Medicine by Design Symposium – Engineering progress in regenerative medicine

Author: Nicole Forgione, 12/21/16

On November 28 local and international leaders of the regenerative medicine (RM) community gathered at the MaRS Centre in Toronto for the first ever Medicine by Design (MbD) Symposium. The event marked the first year of the MbD program at the University of Toronto (U of T). This initiative was established based on a $114…Read more